awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51558091-8ACF4E99-A963-40CA-83F4-F3BCF2AD8D79
Q51558091-8ACF4E99-A963-40CA-83F4-F3BCF2AD8D79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51558091-8ACF4E99-A963-40CA-83F4-F3BCF2AD8D79
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
P2860
Q51558091-8ACF4E99-A963-40CA-83F4-F3BCF2AD8D79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51558091-8ACF4E99-A963-40CA-83F4-F3BCF2AD8D79
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c73de59fbd9c82235c5343f3421826f33830f1a0
P2860
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.